SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

COLOMBO, Gaia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.110
AS - Asia 5.934
EU - Europa 3.446
SA - Sud America 1.144
AF - Africa 145
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 4
Totale 20.816
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.908
SG - Singapore 2.289
CN - Cina 1.460
BR - Brasile 900
IT - Italia 778
VN - Vietnam 623
UA - Ucraina 562
HK - Hong Kong 494
DE - Germania 386
TR - Turchia 331
FR - Francia 318
GB - Regno Unito 302
PL - Polonia 235
FI - Finlandia 218
SE - Svezia 172
JP - Giappone 157
RU - Federazione Russa 153
IN - India 130
MX - Messico 101
ID - Indonesia 88
AR - Argentina 84
CA - Canada 77
NL - Olanda 61
ZA - Sudafrica 59
BD - Bangladesh 58
ES - Italia 52
IQ - Iraq 50
PK - Pakistan 40
EC - Ecuador 36
CO - Colombia 32
GR - Grecia 31
CL - Cile 28
DK - Danimarca 25
IR - Iran 25
AU - Australia 24
VE - Venezuela 24
MY - Malesia 23
AT - Austria 22
CH - Svizzera 21
BE - Belgio 20
SA - Arabia Saudita 19
TN - Tunisia 19
IL - Israele 17
MA - Marocco 17
UZ - Uzbekistan 16
PH - Filippine 15
PY - Paraguay 15
EG - Egitto 14
PE - Perù 14
PT - Portogallo 13
AE - Emirati Arabi Uniti 11
LT - Lituania 11
IE - Irlanda 10
BY - Bielorussia 9
JO - Giordania 9
KE - Kenya 9
KR - Corea 9
NZ - Nuova Zelanda 9
RO - Romania 9
BO - Bolivia 8
CZ - Repubblica Ceca 8
BH - Bahrain 7
DZ - Algeria 7
TH - Thailandia 6
TW - Taiwan 6
AZ - Azerbaigian 5
BG - Bulgaria 5
HU - Ungheria 5
JM - Giamaica 5
KZ - Kazakistan 5
LB - Libano 5
NP - Nepal 5
PA - Panama 5
PS - Palestinian Territory 5
KW - Kuwait 4
AL - Albania 3
CR - Costa Rica 3
HR - Croazia 3
KG - Kirghizistan 3
LV - Lettonia 3
NG - Nigeria 3
OM - Oman 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
ET - Etiopia 2
EU - Europa 2
GA - Gabon 2
GD - Grenada 2
GE - Georgia 2
HN - Honduras 2
KH - Cambogia 2
LY - Libia 2
NO - Norvegia 2
RS - Serbia 2
SC - Seychelles 2
SN - Senegal 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 20.791
Salva come PNG Salva come JPEG
Città #
Singapore 1.447
Fairfield 998
Ashburn 964
Woodbridge 956
Houston 698
Jacksonville 621
Santa Clara 558
Chandler 545
Ann Arbor 472
Hong Kong 468
Beijing 399
San Jose 397
Wilmington 371
Seattle 369
Cambridge 328
Izmir 243
Warsaw 224
Ho Chi Minh City 196
Nanjing 182
Princeton 153
Hanoi 147
Tokyo 144
Lauterbourg 117
Los Angeles 108
Council Bluffs 102
Boardman 100
Ferrara 98
Helsinki 94
Dallas 81
San Diego 77
New York 74
Shenyang 68
São Paulo 63
Milan 55
Mexico City 53
Nanchang 53
Hebei 44
Jakarta 44
Shanghai 44
Tianjin 44
London 40
Haiphong 34
Mountain View 34
Redwood City 33
Da Nang 32
Hefei 31
Moscow 31
Rio de Janeiro 31
Chicago 30
Atlanta 28
Falls Church 28
Frankfurt am Main 28
Jiaxing 28
Munich 28
Rome 27
Bremen 26
Addison 25
Bologna 24
Baghdad 23
Copenhagen 23
Denver 23
Johannesburg 22
Orem 21
Poplar 21
San Francisco 20
Brooklyn 19
Brussels 19
Changsha 19
Parma 19
Columbus 18
Zhengzhou 18
Brasília 16
Falkenstein 16
Jinan 16
Nuremberg 16
Santiago 16
Tashkent 16
The Dalles 16
Belo Horizonte 15
Norwalk 15
Boston 14
Orange 14
Phoenix 14
Guangzhou 13
Manchester 13
Mumbai 13
Philadelphia 13
Stockholm 13
Amsterdam 12
Auburn Hills 12
Des Moines 12
Fortaleza 12
Guayaquil 12
Hangzhou 12
Hải Dương 12
Lahore 12
Naples 12
Sydney 12
Verona 12
Vienna 12
Totale 13.395
Salva come PNG Salva come JPEG
Nome #
Studio di uno spray topico di sucralfato gel e cidofovir per la terapia antivirale di ovini 369
Opportunity and challenges of nasal powders: Drug formulation and delivery 366
PRINCIPI DI CALCOLO FARMACEUTICO 346
In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates 310
Biological In Vitro Models for Absorption by Nonoral Routes 286
The development of a single-use, capsule-free multi-breath tobramycin dry powder inhaler for the treatment of cystic fibrosis 258
Chimerical agglomerates of lecithin/chitosan nanoparticles for powder nasal delivery 249
Effect of residual water content on the physico-chemical properties of sucralfate dried gel obtained by microwave drying 242
Bioadhesive sucralfate gel-based suspension containing cidofovir for spray treatment of viral infections in lamb and sheep 219
Respiratory Drug Delivery 215
Design of experiments (DoE) in pharmaceutical development 211
Assemblage of Novel Release Modules for the Development of Adaptable Drug Delivery Systems 207
Dry powder inhalers: An overview of the in vitro dissolution methodologies and their correlation with the biopharmaceutical aspects of the drug products 206
Nasal powders of thalidomide for local treatment of nose bleeding in persons affected by hereditary hemorrhagic telangiectasia 205
Surface-modified nanocarriers for nose-to-brain delivery: From bioadhesion to targeting 205
Brain Targeting of an Antiischemic Agent by Nasal Administration of Microparticles 204
Bioadhesive film for transdermal delivery of lidocaine: in vitro and in vivo behavior 203
Ex vivo permeation of tamoxifen and its 4-OH metabolite through rat intestine from lecithin/chitosan nanoparticles 201
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients 192
Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation 189
Chitosan coated human serum albumin nanoparticles: A promising strategy for nose-to-brain drug delivery 180
Floating modular drug delivery systems with buoyancy independent of release mechanisms to sustain amoxicillin and clarithromycin intra-gastric concentrations 179
Swellable and Rigid Matrices: Controlled Release Matrices with Cellulose Ethers 178
Artesunate-clindamycin multi-kinetics and site-specific oral delivery system for antimalaric combination products 178
The use of fatty acids as absorption enhancer for pulmonary drug delivery 177
The Effect of Residual Water on Antacid Properties of Sucralfate Gel Dried by Microwaves 175
Alginate and cell combination product for wound healing 174
Bioencapsulation methods for cell inclusion in polysaccharidic matrices for clinical applications 174
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease 174
Skin permeation of 5-methoxypsoralen from topical dosage forms 168
Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells 166
Autoassembled nanoparticles of lecithin/chitosan for oral delivery of the anticancer drug tamoxifen citrate 165
Combination of alginate and cells for skin regeneration 162
Module assemblage technology for floating systems: in vitro flotation and in vivo gastro-retention 160
The suitability of disintegrating force kinetics for studying the effect of manufacturing parameters on spironolactone tablet properties 158
The formulation of a novel macrolide solution pressurised metered dose inhaler: the use of Clarithromycin as an anti-inflammatory for bronchiectasis therapy 157
Novel Platforms for Oral Drug Delivery 156
A Study for the Development of Mesalazine Multiparticulate Dosage Forms for Colon Delivery in Pediatric Patients 155
A new 5-methoxypsoralen formulation for the topical treatment of psoriasis 154
Therapeutic paint of cidofovir/sucralfate gel combination topically administered by spraying for treatment of orf virus infections 153
Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres 153
A Clinical Study of a Methacholine Dry Powder for the Bronchial Challenge Test 151
Nasal administration and brain targeting of an antiischemic agent 150
Prolonged duration local anesthesia with lipid-protein-sugar particles containing bupivacaine and dexamethasone 150
From tablets to pharmaceutical nanotechnologies: Innovation in drug delivery strategies for the administration of antimalarial drugs 150
Soft Agglomerates of Pantoprazole Gastro-resistant Microparticles for Oral Administration and Intestinal Release 149
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 148
In vitro and in vivo study of 5-methoxypsoralen skin concentration after topical application 147
null 147
Formulation Strategies for Antitubercular Drugs by Inhalation 147
Flurbiprofen sodium microparticles and soft pellets for nose-to-brain delivery: Serum and brain levels in rats after nasal insufflation 147
Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid 146
Post-iontophoresis transport of ibuprofen lysine across rabbit ear skin 146
Methacholine dry powder inhaler as a new tool for bronchial challenge test 144
Mechanisms of formation and disintegration of alginate beads obtained by prilling 139
N6-cyclopentyladenosine : selective brain targeting by nasal administration of microparticles 137
Effect of excipient composition on the biocompatibility of bupivacaine-containing microparticles at the sciatic nerve 137
Geometric Release Systems: Principles, Release Mechanisms, Kinetics, Polymer Science, and Release-Modifying Material 135
Brain Uptake of an Antiischemic Agent by Nasal Administration of Microparticles 133
Prolonged duration local anesthesia with lipid-protein-sugar particles containing bupivacaine and dexamethasone 133
Compositions in powder form made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 130
Chitosan-coated nanoparticles: Effect of chitosan molecular weight on nasal transmucosal delivery 129
Single layer dermal patch: skin accumulation assessed by tape stripping 128
Aerodynamic assessment for inhalation products: fundamentals and current pharmacopoeial methods 128
Ex vivo propofol permeation across nasal mucosa: A proof-of-concept study for outpatient light sedation via nasal route 127
Aerosolization performance of jet nebulizers and biopharmaceutical aspects 127
Efficacy and biocompatibility of bupivacaine-loaded lipid-protein-sugar particles for prolonged duration local anesthesia 125
The role of dissolution test in a comparison of generic and branded controlled-release products 125
Diclofenamic acid-vitamin C conjugates: stability and interaction studies with ascorbate transporters 125
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 124
Antidiuretic effect of desmopressin chimera agglomerates by nasal administration in rats 123
null 122
In vitro and in vivo study of a desmopressin nasal powder 120
PRODRUGS, MICRO OR NANOPARTICULATE SYSTEMS AND NASAL ADMNISTRATION AS NON INVASIVE APPROACHES AGAINST BRAIN DISEASES AND AIRBORNE INFECTIONS. LOCO-REGIONAL THERAPY OF CANCER 119
Spray therapeutic paint for topical treatment of orf virus skin infections in breeding sheep 119
Therapeutic paint for simultaneous delivery of sucralfate gel and cidofovir in the treatment of veterinary viral skin infections 119
Film for active ingredients dermal and transdermal administration 119
Nasal powders of morphine microcrystals agglomerates 118
Strategies in bupivacaine delivery for prolonged duration local anesthesia 117
Nasal powders of quercetin-β-cyclodextrin derivatives complexes with mannitol/lecithin microparticles for Nose-to-Brain delivery: In vitro and ex vivo evaluation 116
Brain distribution of ribavirin after intranasal administration 115
Soft agglomerates containing microencapsulated levothyroxine for buccal or oral delivery 115
Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems 115
In vitro comparison of four anti-inflammatory topical medications 114
Development of artemisinin - β-cyclodextrin complex agglomerates 114
In vitro transport studies across excised nasal mucosa for three drug candidates to nose-to-brain delivery 114
Development of a spray-dried powder for nasal administration of desmopressin acetate 112
New modules, new assemblage kits and new assemblies for the controlled release of substances 112
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: The enhancing effect of potassium sorbate 112
Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect 112
Comparative Serum and Brain Pharmacokinetics of Quercetin after Oral and Nasal Administration to Rats as Lyophilized Complexes with β-Cyclodextrin Derivatives and Their Blends with Mannitol/Lecithin Microparticles 111
Enhancing ribavirin nose-to-brain delivery by powder formulation for veterinary CNS infections 111
Advanced Dome cellulose/alginate/chitosan composite matrix design with gastric and intestinal co-targeting capacities 110
Rheological, thermal and spectroscopical properties of the macromolecular complex between sodium hyaluronate and cisplatin for anticancer chemotherapy 109
Progesterone-loaded lecithin/chitosan isopropylmyristate nanoparticles for transmucosal delivery 109
Soft chimera agglomerates for desmopressin nasal administration: an in vitro and in vivo study 108
Produzione e caratterizzazione di nanoparticelle ottenute dall'interazione ionica tra lecitina e chitosano 107
Orphan Designation and Cisplatin/Hyaluronan Complex in an Intracavitary Film for Malignant Mesothelioma 107
null 106
Construction of amikacin dry powders for inhalation by a Central Composite Design 106
Totale 15.794
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.673
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.388
Totale 90.061
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021288 0 0 0 0 0 0 0 0 0 0 188 100
2021/20221.265 51 154 98 66 55 76 44 76 41 101 118 385
2022/20231.299 164 54 27 159 238 193 34 127 167 15 86 35
2023/2024608 93 91 34 23 41 25 15 28 9 28 55 166
2024/20252.881 93 46 229 87 433 317 173 165 445 344 301 248
2025/20267.210 561 435 730 1.059 939 488 731 561 753 936 17 0
Totale 21.046